3EO Health COVID-19 Starter Kit

The 3EO Health COVID-19 Test is a single-use test kit intended for the qualitative detection of nucleic acid from the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is for non-prescription home use or laboratory/professional use with self-collected Anterior Nasal (AN) swab specimens in individuals aged 14 years and older or individuals under 2 years old (collected by an adult) with symptoms of COVID-19.

This test is similar to a PCR test in that it utilizes molecular amplification technology for the detection of SARS-CoV-2 RNA. This viral RNA is generally detectable in a swab specimen during the acute phase of infection. The 3EO Health COVID-19 Test, comprised of the 3EO ‘Swab” and reagent-containing 3EO “Key,” is to be used with the 3EO “Cube” (base unit/test reader) instrument.

Low-cost, Easy-to-use, Molecular Testing at POC:

  • MOLECULAR: 3EO’s novel 3TR amplification technology delivers nucleic acid amplification and detection down to 733 copies per mL – 1000x more sensitive than antigen with PPA:95%; NPA:100%.
  • EASY-TO-USE: Simple sample-to-test workflow in a 3-in x 3-in footprint. No initiation, no set-up, no caps, no mixing, no pipetting, no timing.
  • LOW COST: 40 – 70% less expensive than existing technologies and under the elasticity bar. No contract or maintenance required.
SKIT-COV19 COVID-19 Starter Kit, Includes: Cube and (2) COVID-19 Tests (US Only)
TPK-2-COV19 CCOVID-19 2 Test Pack, Includes: (2) COVID-19 Tests (US Only)
TPK-20-COV19 COVID-19 20 Test Pack, Includes: (20) COVID-19 Tests (US Only)


AmeriCan Goods Program Details:
AmeriCan Goods Warehouse Program
Available to Medical and MedPlus Dealers Only
Available in the US ONLY
Markets: Physician/Clinic, Acute Care/Surgery Center, Long Term Care/Post-Acute, Physical/Occupational Therapy, Hospital, Nursing Home, Laboratory, Home Health Care, Government, Emergency – EMS
CPT Code/Description 87635 – Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), AMPLIFIED PROBE TECHNIQUE. National Average Reimbursement – $51.31
Contact: Allan Raukhman, 718.269.1166